Skip to main content

Table 4 Potential complications of infection among hospitalized STEMI patients (n = 11, 879)* in Florida, 2006.

From: Prevalence of major infections and adverse outcomes among hospitalized. ST-elevation myocardial infarction patients in Florida, 2006

 

Non-Infected STEMI Patients

n = 9, 910

% (n)

Blood Stream Infection

n = 310

% (n)

Pneumonia

n = 550

% (n)

Surgical Site Infection

n = 491

% (n)

Urinary Tract Infection

n = 708

% (n)

All Other Infections

n = 503

% (n)

Potential Complications of Infection§

      

Acute renal failure

5.3 (526)

51.3 (158)**

30.6 (168)**

15.5 (76)**

28.8 (204)**

23.1 (116)**

Heart failure

18.0 (1776)

58.8 (181)**

63.5 (349)**

26.9 (132)**

50.6 (358)**

46.9 (236)**

Swan-Ganz catheter

1.3 (129)

8.8 (27)**

5.1 (28)**

3.9 (19)**

4.0 (28)**

5.0 (25)**

Mechanical ventilation

5.4 (537)

14.9 (46)**

13.1 (72)**

21.2 (104)**

8.5 (60)**

25.1 (126)**

Intensive care unit stay

64.0 (6339)

69.8 (215) ‡‡

69.3 (381) ‡‡

68.2 (335) ‡‡

70.6 (500)^

67.8 (341)

Length of stay 7+ days

15.5 (1535)

75.7 (233)**

65.5 (360)**

44.8 (220)**

57.6 (408)**

61.6 (310)**

In-hospital mortality

6.5 (640)

31.3 (97)**

19.6 (108)**

7.9 (39)

11.0 (78)**

7.4 (37)

  1. * Excludes patients who were transferred to another hospital.
  2. ** p < .0001; †† p < .01; ‡‡ p < .05; §§ p = .0001
  3. † Patients can appear in more than one infection category.
  4. ‡ Includes lower respiratory, gastrointestinal, cardiovascular, bone and joint, ear, eye, nose & throat, skin and soft tissue, and site unspecified bacterial infections.
  5. § Chi-square tests of homogeneity were conducted to compare potential complicating factors of each infection to non-infected STEMI patients.